ONTOLOGY REPORT - ANNOTATIONS


Term:disease population measurement
go back to main search page
Accession:CMO:0001149 term browser browse the term
Definition:Any measurement which deals with a disease in terms of population, geography or demographics.
Synonyms:related_synonym: disease demographics measurement


show annotations for term's descendants       view all columns           Sort by:
 
cataract incidence/prevalence measurement term browser
Symbol Object Name JBrowse Chr Start Stop Reference
Q Arrd3 Age-related retinal degeneration QTL 3 JBrowse link 1 202,571,665 264,802,994 RGD:7794750
encephalitis incidence/prevalence measurement term browser
Symbol Object Name JBrowse Chr Start Stop Reference
Q Vie1 Viral induced encephalitis QTL 1 JBrowse link 4 31,825,560 83,531,021 RGD:7240516
Q Vie2 Viral induced encephalitis QTL 2 JBrowse link 3 153,412,455 177,699,992 RGD:7240516
Q Vie3 Viral induced encephalitis QTL 3 JBrowse link 6 101,207,574 147,991,367 RGD:7240516
Q Vie4 Viral induced encephalitis QTL 4 JBrowse link 4 61,708,341 83,531,021 RGD:7240516
Q Vie5 Viral induced encephalitis QTL 5 JBrowse link 4 31,825,560 83,531,021 RGD:7240516
experimental autoimmune encephalomyelitis incidence/prevalence measurement term browser
Symbol Object Name JBrowse Chr Start Stop Reference
Q Eae12 Experimental allergic encephalomyelitis QTL 12 JBrowse link 10 95,508,221 104,329,177 RGD:69695
Q Eae13 Experimental allergic encephalomyelitis QTL 13 JBrowse link 12 27,190,240 42,196,641 RGD:69695
Q Eae14 Experimental allergic encephalomyelitis QTL 14 JBrowse link 13 28,584,452 73,584,452 RGD:69695
Q Eae15 Experimental allergic encephalomyelitis QTL 15 JBrowse link 18 79,948,616 80,696,375 RGD:69695
Q Eae16 Experimental allergic encephalomyelitis QTL 16 JBrowse link 8 9,531,047 119,211,942 RGD:629629
Q Eae17 Experimental allergic encephalomyelitis QTL 17 JBrowse link 13 12,193,394 108,478,121 RGD:629629
Q Eae2 Experimental allergic encephalomyelitis QTL 2 JBrowse link 4 18,222,187 37,685,319 RGD:69694
Q Eae3 Experimental allergic encephalomyelitis QTL 3 JBrowse link 10 27,237,530 64,648,311 RGD:69694
Q Eae4 Experimental allergic encephalomyelitis QTL 4 JBrowse link 9 1 29,467,098 RGD:69712
mammary tumor incidence/prevalence measurement term browser
Symbol Object Name JBrowse Chr Start Stop Reference
Q Mcs31 Mammary carcinoma susceptibility QTL 31 JBrowse link 9 90,024,661 119,983,851 RGD:7794780
Q Mcs32 Mammary carcinoma susceptibility QTL 32 JBrowse link 1 122,614,824 262,664,716 RGD:7794780
Q Mcs33 Mammary carcinoma susceptibility QTL 33 JBrowse link 5 136,640,731 173,707,219 RGD:7794780
Q Mcs34 Mammary carcinoma susceptibility QTL 34 RGD:7794780
percentage of study population developing cerebrovascular lesions during a period of time term browser
Symbol Object Name JBrowse Chr Start Stop Reference
Q Strs4 Sensitivity to stroke QTL 4 JBrowse link 1 79,689,548 124,689,548 RGD:7411685
Q Strs5 Sensitivity to stroke QTL 5 JBrowse link 18 51,609,032 67,502,266 RGD:7411685
Q Strs6 Sensitivity to stroke QTL 6 JBrowse link 5 140,387,005 143,846,157 RGD:7411685
Q Strs7 Sensitivity to stroke QTL 7 JBrowse link 15 42,757,241 56,027,084 RGD:7411685
percentage of study population developing diabetes mellitus during a period of time term browser
Symbol Object Name JBrowse Chr Start Stop Reference
Q Iddm15 Insulin dependent diabetes mellitus QTL 15 JBrowse link 18 62,805,406 80,696,375 RGD:619685
Q Iddm18 Insulin dependent diabetes mellitus QTL 18 JBrowse link 6 121,224,054 135,658,578 RGD:619685
Q Iddm20 Insulin dependent diabetes mellitus QTL 20 JBrowse link 17 14,009,679 23,316,697 RGD:1358924
percentage of study population developing endometrioid carcinoma during a period of time term browser
Symbol Object Name JBrowse Chr Start Stop Reference
Q Edcs1 Endometrial carcinoma susceptibility QTL1 JBrowse link 11 19,016,272 25,069,932 RGD:1599856
Q Edcs2 Endometrial carcinoma susceptibility QTL2 JBrowse link 12 8,249,608 20,590,080 RGD:1599856
Q Edcs3 Endometrial carcinoma susceptibility QTL3 JBrowse link 20 1 25,653,396 RGD:1599856
Q Edcs4 Endometrial carcinoma susceptibility QTL 4 JBrowse link 1 226,706,329 271,706,329 RGD:1599856
Q Edcs5 Endometrial carcinoma susceptibility QTL 5 JBrowse link 17 62,195,703 74,702,206 RGD:1599856
percentage of study population developing experimental autoimmune encephalomyelitis during a period of time term browser
Symbol Object Name JBrowse Chr Start Stop Reference
Q Eae20 Experimental allergic encephalomyelitis QTL 20 JBrowse link 4 152,482,121 158,564,471 RGD:1547849
Q Eae24 Experimental allergic encephalomyelitis QTL 24 JBrowse link 4 65,987,814 73,372,824 RGD:2317591
Q Eae25 Experimental allergic encephalomyelitis QTL 25 JBrowse link 4 79,559,380 84,053,053 RGD:2317591
Q Eae27 Experimental allergic encephalomyelitis QTL 27 JBrowse link 4 99,066,972 110,635,449 RGD:2317591
Q Eae8 Experimental allergic encephalomyelitis QTL 8 JBrowse link 19 24,457,627 37,140,233 RGD:61031
percentage of study population developing mammary tumors during a period of time term browser
Symbol Object Name JBrowse Chr Start Stop Reference
Q Emca4 Estrogen-induced mammary cancer QTL 4 JBrowse link 7 69,399,586 111,043,530 RGD:1642522
Q Emca5 Estrogen-induced mammary cancer QTL 5 JBrowse link 3 45,406,058 177,699,992 RGD:1642522
percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of time term browser
Symbol Object Name JBrowse Chr Start Stop Reference
Q Eae10 Experimental allergic encephalomyelitis QTL 10 JBrowse link 14 19,191,664 19,909,740 RGD:61031
Q Eae5 Experimental allergic encephalomyelitis QTL 5 JBrowse link 12 22,650,702 52,716,770 RGD:61031
percentage of study population developing retinopathy during a period of time term browser
Symbol Object Name JBrowse Chr Start Stop Reference
Q Arrd1 Age-related retinal degeneration QTL 1 JBrowse link 1 106,002,252 202,571,904 RGD:7794750
Q Arrd2 Age-related retinal degeneration QTL 2 JBrowse link 1 202,571,665 264,802,994 RGD:7794750
percentage of study population developing T-cell lymphomas during a period of time term browser
Symbol Object Name JBrowse Chr Start Stop Reference
Q Tls2 T-lymphoma susceptibility QTL 2 JBrowse link 7 88,365,265 119,318,087 RGD:619600
Q Tls3 T-lymphoma susceptibility QTL 3 JBrowse link 10 53,625,815 98,939,209 RGD:619600
percentage of study population developing testis tumors during a period of time term browser
Symbol Object Name JBrowse Chr Start Stop Reference
Q Tescar1 Testicular tumor resistance QTL 1 JBrowse link 11 325,031 69,342,559 RGD:1358944
percentage of study population developing trigeminal nerve neurilemmomas during a period of time term browser
Symbol Object Name JBrowse Chr Start Stop Reference
Q Schws1 Schwannoma susceptibility QTL 1 JBrowse link 10 41,260,363 106,105,607 RGD:1559300
Q Schws2 Schwannoma susceptibility QTL 2 RGD:1559300
Q Schws3 Schwannoma susceptibility QTL 3 JBrowse link 3 125,848,628 170,848,628 RGD:1559300
Q Schws4 Schwannoma susceptibility QTL 4 JBrowse link 6 87,418,448 111,129,520 RGD:1559300
Q Schws7 Schwannoma susceptibility QTL 7 JBrowse link 10 4,835,638 20,170,031 RGD:1559300
Q Schws8 Schwannoma susceptibility QTL 8 JBrowse link 6 99,273,921 144,273,921 RGD:11566050
Q Schws9 Schwannoma susceptibility QTL 9 JBrowse link 6 66,129,520 111,129,520 RGD:11566050
percentage of study population developing unilateral renal agenesis during a period of time term browser
Symbol Object Name JBrowse Chr Start Stop Reference
Q Renag1 Renal agenesis QTL 1 JBrowse link 14 9,756,435 72,854,397 RGD:1580355
percentage of study population developing ventral prostate tumorous lesions during a period of time term browser
Symbol Object Name JBrowse Chr Start Stop Reference
Q Prcs1 Prostate cancer susceptibility QTL 1 JBrowse link 19 15,939,528 38,798,459 RGD:1358944
Q Prcs2 Prostate cancer susceptibility QTL 2 JBrowse link 20 4,039,113 18,872,273 RGD:1358944
percentage of study population displaying chronic pancreatitis at a point in time term browser
Symbol Object Name JBrowse Chr Start Stop Reference
Q Panci1 Pancreas inflammation QTL 1 JBrowse link 7 126,463,827 137,325,116 RGD:619682
percentage of study population displaying Toxoplasma gondii brain cysts at a point in time term browser
Symbol Object Name JBrowse Chr Start Stop Reference
Q Toxo1 Toxoplasma gondii resistance QTL 1 JBrowse link 10 54,057,616 61,300,905 RGD:1578521

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 2370
    disease population measurement 57
      disease incidence/prevalence measurement + 57
paths to the root